Adilip 135 Tablet

Composition of Adilip 135 Tablet

Adilip 135 Tablet contains Fenofibrate 135 mg (as fenofibrate) tablet. It belongs to the Fibrate (PPAR-alpha agonist) class of medicines.

Uses of Adilip 135 Tablet

Treatment of dyslipidaemia such as high triglycerides (hypertriglyceridaemia) and mixed dyslipidaemia; used to reduce risk of pancreatitis associated with very high triglycerides; adjunct to diet and lifestyle changes.

Key benefits

• Lowers high triglycerides
• Reduces VLDL and total cholesterol
• May increase HDL (good cholesterol)
• Helps manage mixed dyslipidaemia along with diet and exercise

How Adilip 135 Tablet works

Fenofibrate activates PPAR-α, which increases lipolysis and clearance of triglyceride-rich lipoproteins by inducing lipoprotein lipase and reducing apolipoprotein C-III. This lowers triglycerides and VLDL and can raise HDL cholesterol.

How to take Adilip 135 Tablet

Oral tablet. Take as prescribed by the doctor, usually once daily; best taken with or after food to improve absorption. Swallow whole with water; continue diet, exercise and weight control alongside therapy.

Take it exactly as your doctor prescribed. Do not change the dose or stop early on your own.

Missed dose and overdose

If you miss a dose

Take it as soon as you remember. If your next dose is almost due, skip the one you missed — never take two doses together to catch up.

If you take too much

An overdose of this medicine is unlikely to cause immediate harm but may increase the risk of muscle and liver injury. Do not wait for symptoms to appear — go to the nearest emergency department and take the pack or strip with you.

Side effects of Adilip 135 Tablet

Most side effects of Adilip are mild and settle as the body adjusts. Reported side effects include:

• Abdominal pain
• nausea
• diarrhoea
• indigestion
• headache
• raised liver enzymes
• back pain
• muscle pain

Stop the medicine and seek help immediately for a rash, swelling of the face or lips, wheezing or difficulty breathing. Tell your doctor about any side effect that persists or worries you.

Safety advice for Adilip 135 Tablet

Warnings and precautions

Not for use in severe kidney disease, active liver disease, gallbladder disease, or allergy to fenofibrate/fibric acid derivatives. Risk of muscle toxicity (myopathy/rhabdomyolysis), especially with statins, in elderly, diabetes, hypothyroidism or renal impairment—report unexplained muscle pain/weakness. Periodic monitoring of liver function tests, renal function and lipid profile is recommended. May increase risk of gallstones and pancreatitis; stop and seek care if severe abdominal pain occurs.

Do not take Adilip if

Not for anyone with a known allergy to this medicine or to any ingredient in the pack. Must not be used in pregnancy or while breastfeeding. Not for people with active liver disease.

Interactions with other medicines

Statins (increased myopathy risk), warfarin/other anticoagulants (may increase bleeding—monitor INR), cyclosporine/tacrolimus (renal risk), bile acid sequestrants like cholestyramine/colestipol (reduced absorption—separate dosing), glitazones such as pioglitazone/rosiglitazone (lipid changes; monitor)

How to store Adilip 135 Tablet

Store at room temperature (below 25°C), protected from moisture and light. Keep in original blister pack and out of reach of children.

Expert advice for Adilip 135 Tablet

Continue your diet, exercise and, above all, stopping smoking — the medicine adds to these, not replaces them. Get your lipid profile repeated as your doctor advises.

Manufacturer and class

Manufacturer:

INTAS PHARMACEUTICALS`

Therapeutic class:

Antihyperlipidaemic

Drug class:

Fibrate (PPAR-alpha agonist)